Hend M El Tayebi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Top Venues

European journal of clinical investigation

International journal of molecular sciences

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Asmaa Ashraf Mohamed, Monica Armanious, Rana W Bedair, Nada Sherif Amin, Hend M El Tayebi
When less is more: The association between the expression of polymorphic CYPs and AFB1-induced HCC. European journal of clinical investigation (2024)
Sawsan Elgohary, Reda A Eissa, Hend M El Tayebi
Thymoquinone, a Novel Multi-Strike Inhibitor of Pro-Tumorigenic Breast Cancer (BC) Markers: CALR, NLRP3 Pathway and sPD-L1 in PBMCs of HR+ and TNBC Patients. International journal of molecular sciences 24 (18) (2023)
Sawsan Elgohary, Hend M El Tayebi
Inflammasomes in breast cancer: the ignition spark of progression and resistance? Expert reviews in molecular medicine 25 (2023)
Monica A Kamal, Yasmine M Mandour, Mostafa K Abd El-Aziz, Ulrike Stein, Hend M El Tayebi
Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges. Molecules (Basel, Switzerland) 27 (17) (2022)
Hoda T Amer, Ulrike Stein, Hend M El Tayebi
The Monocyte, a Maestro in the Tumor Microenvironment (TME) of Breast Cancer. Cancers 14 (21) (2022)
Sawsan Elgohary, Aya A Elkhodiry, Nada S Amin, Ulrike Stein, Hend M El Tayebi
Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? Cells 10 (2) (2021)
Sara M Atwa, Margarete Odenthal, Hend M El Tayebi
Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. Cancers 13 (17) (2021)